[ad_1] As many as 82.2 lakh shares or 2% equity of Syngene International worth ₹706 crore changed hands at ₹858.5 apiece in block deals on Tuesday, December 10. Company Value Change %Change On Monday, December 9, CNBC-TV18 reported, citing sources, that biotechnology firm Biocon Ltd was likely to sell 2% stake in Syngene International via […]
Syngene International Block Deal: Biocon likely to sell 2% stake at ₹825 per share – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd is likely to sell a 2% stake in contract research and manufacturing services firm Syngene International Ltd through block deals, with the indicative price for the sale pegged at ₹825 per share, sources privy to the developments told CNBC-TV18. Company Value Change %Change This represents a discount of 0-4.9% to […]